ULTRALIFE CORP 8-K

What Happened
Ultralife Corporation (ULBI) filed a Form 8-K on March 10, 2026 to report its results of operations and financial condition for the fourth quarter ended December 31, 2025. The company issued a press release with the quarterly results, which is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: March 10, 2026 (Form 8-K, Items 2.02 and 9.01).
• Reporting period: Quarter ended December 31, 2025.
• Press release attached as Exhibit 99.1; iXBRL cover page included as Exhibit 104.
• Ticker: ULBI; accession number for the filing: 0001437749-26-007567.

Why It Matters
This 8-K signals Ultralife has released its latest quarterly earnings and related financial information. Investors should review the attached press release (Exhibit 99.1) for the company’s revenue, net income (or loss), EPS, any commentary on trends or guidance, and management statements—details that can affect near-term stock performance and valuation. For full figures and context, consult the press release and the company’s filings on SEC EDGAR.